Russell Hirsch is a Managing Director of Prospect Venture Partners and a former member of the Health Care Technology Group at the venture capital fund Mayfield, where he played a key role in their investment activities in the biotechnology and medical device sectors. Before entering the venture capital field, Hirsch did biomedical research on hepatitis B viral replication at UC San Francisco, where he earned his M.D. and Ph.D. degrees.
CITRIS and the Banatao Institute
Creating information technology solutions for society's most pressing challenges